Detalhe da pesquisa
1.
Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South India.
Clin Lymphoma Myeloma Leuk
; 20(5): e205-e211, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146105